SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-065444
Filing Date
2021-12-15
Accepted
2021-12-15 16:10:59
Documents
76
Period of Report
2021-10-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1021_enzobiochem.htm   iXBRL 10-Q 656664
2 EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN THE COMPANY AND HAMID ERFANIAN, DATED OCT f10q1021ex10-1_enzobio.htm EX-10.1 80113
3 CERTIFICATION f10q1021ex31-1_enzobio.htm EX-31.1 10132
4 CERTIFICATION f10q1021ex31-2_enzobio.htm EX-31.2 10060
5 CERTIFICATION f10q1021ex32-1_enzobio.htm EX-32.1 3846
6 CERTIFICATION f10q1021ex32-2_enzobio.htm EX-32.2 4080
  Complete submission text file 0001213900-21-065444.txt   4810248

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE enz-20211031.xsd EX-101.SCH 59460
8 XBRL CALCULATION FILE enz-20211031_cal.xml EX-101.CAL 41859
9 XBRL DEFINITION FILE enz-20211031_def.xml EX-101.DEF 246263
10 XBRL LABEL FILE enz-20211031_lab.xml EX-101.LAB 474551
11 XBRL PRESENTATION FILE enz-20211031_pre.xml EX-101.PRE 257033
12 EXTRACTED XBRL INSTANCE DOCUMENT f10q1021_enzobiochem_htm.xml XML 585562
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 211494332
SIC: 8071 Services-Medical Laboratories